While ESR1 mutations are a well-established mechanism of resistance to ET, it is less clear if specific types of ETs, such as AI plus/minus LHRHa or TAM plus/minus LHRHa, are more likely to cause the selection of tumor clones bearing ESR1 gene mutations. The gene discussed is ESR1; the disease is neoplasm.